9c46145e_nter___Yale_School_of_Medicine__Conditions
[Study Title] Phase 1 Study of Mogamulizumab (KW-0761) in Combination with MEDI4736 and Mogamulizumab in Combination with Tremelimumab in Subjects with Advanced Solid Tumors [Conditions] 
Soft Tissue
M e l a n o m a , s k i n
S o f t T i s s u e
Mario Sznol, MD > Yale Cancer Center | Yale School of Medicine
Conditions